Brief: Ephraim Fields Reports 9.3% Stake In Neurometrix, Inc. As Of Feb 23, 2024 - SEC Filing
27/02/2024 22:01
NeuroMetrix Inc NURO.O :
* EPHRAIM FIELDS REPORTS 9.3% STAKE IN NEUROMETRIX, INC. AS
OF FEB
23, 2024 - SEC FILING
* EPHRAIM FIELDS SAYS PURCHASED NEUROMETRIC COMMON STOCK
BASED ON
BELIEF THAT COMMON STOCK, WHEN PURCHASED, WERE "UNDERVALUED"
Source text for Eikon: ID:n0001683168-24-001211
Further company coverage: NURO.O
Recent news on NeuroMetrix
See all newsBrief: Neurometrix To Be Acquired By Electrocore
Brief: Neurometrix Reiterates Its Review Of Strategic Alternatives
Brief: NeuroMetrix Announces Steps Taken To Enhance Shareholder Value
Brief: Ephraim Fields Reports 9.3% Stake In Neurometrix, Inc. As Of Feb 23, 2024 - SEC Filing
Brief: RS Fund Reports 14.4% Stake In Neurometrix Inc As Of Feb 13